Best GLP-1 Microdosing Providers (2026): Every Published Price, Ranked
Compare published prices for 548 GLP-1 providers, from named microdose programs to standard-dose plans. Affiliate partners are listed first. Microdosing is off-label and unproven.
Some of the providers here pay us a commission when a reader starts through our link, and we say so at the top of the ladder as well as in our disclosure; what we write about a provider is the same either way. The order is commercial, not a score: our featured partner comes first, then the other providers that pay us, then everyone else, and inside each group the order is the one our editor set by hand. There is no numeric score or grade behind it. What we check and print on every card, partner or not, is below. None of this makes microdosing itself proven — it is off-label, with no dedicated randomized trials.
The price ladder
30 providers · monthly cost
Affiliate-funded: some of the providers below pay us a commission if you start through our link, at no extra cost to you — what we write about each one is the same either way (disclosure). Microdosing is off-label and unproven (evidence).
Showing 30 providers across all six pricing groups. Continue through the linked comparison pages to browse all 548 providers.
Charges less for less
5 of 42 providers
Publishes a named low-dose product at a lower price than its own full-dose equivalent. Taking a smaller amount genuinely costs less here, which is the structure this page is looking for.
Enhance MDPartner
A capped 1 mg weekly tirzepatide microdose priced below its standard tirzepatide at every plan length, with labs and provider visits included.
Main trade-off: The microdose has no month-to-month option: the shortest plan is three months, billed every 12 weeks
A named microdose of either molecule priced below its standard injection, beside lozenges and drops.
Main trade-off: The semaglutide microdose is listed at 0.2 mg, the same dose the standard injection starts at, so early on the saving is in the price rather than the dose; the tirzepatide microdose gives no milligram
Sells a microdose as its own named product, priced below its own full dose.
Main trade-off: Every price is an "as low as" that depends on plan length — the microdose page shows $279 struck through above the $116, and the tiers in between are not published, so a month-to-month microdoser cannot work out their real cost
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
Try Ageless
A broad compounded storefront that prices each GLP-1 by the prescribed dose, so the lowest strengths cost the least.
Main trade-off: The exact price is shown only after clinical review, so the dose-based range is all you can cost in advance
Prices its plans off the LOWEST dose — the one pricing model here that does not penalize taking less.
Main trade-off: No pricing at all on the public site — the molecule behind its "from $199" is never named, and tirzepatide figures appear only inside the intake
Publishes an eleven-rung price ladder with a milligram figure against every rung — and advertises two entry prices that appear on none of them.
Main trade-off: The main GLP-1 page advertises "Starts at $199/month" and $199 appears at no rung of Elara's own published ladder — the cheapest semaglutide price it actually publishes is $249 at 0.2 mg/week. That page carries exactly one dollar figure and no milligram figure at all
Prices each vial by the dose it holds, so a 0.25 mg/week microdose buys ten weeks of supply for the price of a five-week one.
Main trade-off: The advertised figures are PER-VIAL prices whose supply duration swings between four and ten weeks depending on the dose, so no number on the page is a monthly rate and two of them cannot be compared without doing the arithmetic yourself
Not one flat figure · Labs optional · Pharmacy not named · Dietitian included · our Aspire Health review
One of the few here that charges by the dose — and the only saving it advertises is measured against a higher dose than the one you are buying.
Main trade-off: The bundle block advertises "Starts at $199 $159", but $199 is not a former price of the 0.25 mg rung — it is what Coby charges for the NEXT dose up, 0.50 mg. The saving is displayed against a higher dose than the one being sold
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
CoreAge RxFeatured partner
Two named microdosing programs with their own monthly prices, sold beside standard plans that cost less.
Main trade-off: Each microdosing product costs more per month than the standard plan for the same molecule, so the named low-dose route is the dearer way to take less
Sells both molecules as named Microdose Programs — beside an ivermectin shelf that has nothing to do with either.
Main trade-off: The same storefront retails ivermectin and an ivermectin + mebendazole combination alongside the GLP-1 line; the FDA has publicly warned against using ivermectin outside its approved labels, and a metabolic prescriber stocking it is a judgment signal about the whole catalog
The only thing it sells is a microdose — and it prints outcome ranges for one that no trial has produced.
Main trade-off: The homepage prints expected nausea rates, lean-mass retention and result ranges for a 1 mg microdose — figures extrapolated from full-dose and observational data, not measured on the protocol being sold, which is exactly the overreach this site was built to flag
One stated price across doses. A lower dose does not automatically reduce the bill. Compare the complete medication, membership, laboratory and shipping quotes before assuming another plan costs less.
FoundPartner
Long-running physician-led weight care with a GLP-1 microdosing program, priced flat at every dose on cash or insurance plans.
Main trade-off: The microdose has no lower price: the plan costs the same at every dose, so taking less saves nothing
Not one flat figure · Labs optional · 503A/503B, not named · Dietitian included · our Found review
From $169/mo on 12-mo prepay · $289/mo month to month
Promises in writing that the price never moves when the dose does — on standard-dose plans, with no microdose product behind the promise.
Main trade-off: No microdose or low-dose GLP-1 product of any kind — the word does not appear anywhere on the site or in its application bundle, so starting low here means self-directing a smaller amount inside a standard-dose plan at the standard plan's price
The Bodybuilding.com fitness brand's new compounded-telehealth arm — budget sema/tirz bundles with publicly listed pricing.
Main trade-off: Its tirzepatide bundles cost MORE per month than paying monthly — $286 at three months, $250 at six and $244 at twelve, against $209 month-to-month — while all three are badged as savings and the 12-month one as "Best Value · Save $586". Only the semaglutide ladder actually descends, so committing longer on tirzepatide raises your monthly cost rather than lowering it
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
WellorithmPartner
A dissolving GLP-1 tablet suited to a small dose, and four priced brand-name pens, but no price for the compounded line.
Main trade-off: No price for the compounded injection or the dissolving tablets, which have no product pages; every link leads to an intake quiz, so what a small dose costs cannot be known before signing up
Advertises one price for every dosage — and nine different starting figures, not one of which it attaches a term to.
Main trade-off: The flat-price finding here is Oak's own marketing rather than our inference: "One price · All dosages" and "All doses are the same price". Billed that way, someone holding at a starter dose pays exactly what someone at the top of the range pays — and Oak publishes no low-dose or microdose product to move to instead
Not one flat figure · No labs · Pharmacy not named · our Oak review
Calls its program a microdose and never publishes the dose — but weighs your muscle every week.
Main trade-off: No milligram figure is published anywhere — including on the page titled "Microdose GLP-1 Rx Program" and at the checkout, which says only that the provider sets the final dose. Nothing published anywhere tells you what dose $199 buys
Branded-first GLP-1 program with a microdose track, bundled into a coaching subscription.
Main trade-off: THE MONTH IS FOUR WEEKS. Billing is $537 per 12 weeks recurring, which is about $2,327 a year against the $2,148 that "$179/month" implies — roughly 8.3% more than the headline reads
Not one flat figure · Labs optional · Pharmacy network · our Noom Med review
Each figure is the provider's own published price, printed word for word — several of them bill a membership, a visit, or a lab panel on top of the medication, and “not one flat figure” is the tell. Verified against each provider's site in 2026; prices change without notice.
Every card prints the same things: the published price, whether it is all-in, who reviews the intake, and what support is included. CoreAge Rx is our featured partner — named microdosing products at $149/month (semaglutide) and $199/month (tirzepatide), each priced above its own $99/$149 standard plan, with no membership fee.
A note before you read on: intentional GLP-1 microdosing is currently off-label and unproven — there are no dedicated randomized trials of sub-therapeutic GLP-1 dosing. This list compares what providers charge and include, not a claim that microdosing is clinically proven. Start with our microdosing GLP-1 evidence review.
FTC disclosure. We have affiliate or referral partnerships with some of the providers ranked here, and may earn a commission at no extra cost to you when you start through one of our links. Partners are labeled, and each comparison keeps the provider's published price qualifiers and known limitations. Payment does not make a treatment proven or a provider suitable for you. See our full disclosure.
Featured partner
$149–$199/mo microdose ($99–$149 standard)
1
CoreAge RxFeatured partner
Two named microdosing programs with their own monthly prices, sold beside standard plans that cost less.
Semaglutide Microdosing Therapy $149/mo · Tirzepatide Microdosing Therapy $199/mo · standard semaglutide $99/mo and tirzepatide $149/mo, same price at every dose · no membership fee
CoreAge Rx sells compounded semaglutide and tirzepatide online, with a short health questionnaire reviewed by U.S. board-certified physicians, who usually answer within about 24 hours; some states require a live chat or video visit first. Beside its standard weight-loss plans it sells two named low-dose products, a Semaglutide Microdosing Therapy and a Tirzepatide Microdosing Therapy, framed around metabolic health and healthy aging rather than fast weight loss, and neither page states a milligram. Each microdose product costs more per month than the standard plan for the same molecule, and the standard plans are priced the same at every dose. You pay at checkout, before a physician reviews you, and the payment is refunded in full if you are not approved. There is no membership fee and no insurance billing. Shipping is free, by no-signature delivery, and the medication comes from partner pharmacies that the company names only if you contact support. Medications cannot be returned once they ship.
Strengths
Two named microdosing products, one per molecule, each with a monthly price published on its own page
No membership fee, and the price set at checkout is held as your dose rises
A full automatic refund if the physician does not approve your prescription
Physician reply usually within about 24 hours, with round-the-clock support and a member community
Free no-signature shipping, with supplies included on the standard plans
Trade-offs
Each microdosing product costs more per month than the standard plan for the same molecule, so the named low-dose route is the dearer way to take less
No milligram is published for either microdosing product
The dispensing pharmacy is not named on the site; you have to ask support
You are charged before a physician reviews you, and every sale is final once medication ships
Its FAQ says there are no auto-rebills, while its refund policy describes subscriptions that renew automatically until you cancel
Like all compounded GLP-1s, the product is not FDA-approved, and intentional microdosing is off-label and unproven (see our evidence review)
Start with CoreAge Rx — from $99/moMicrodosing is off-label and unproven — decide with a clinician. Prices verified in 2026; confirm current terms.
The rest of the field
Real telehealth providers selling a GLP-1 that can be taken at a low dose — some through a named low-dose program, many only through a standard plan — each read against its own site. We only state a price where the provider published one we could confirm; where pricing is gated behind an eligibility request, we say so.
Start with the price groups above, then follow the comparison page links for the rest of each group. Each row includes the published price or price uncertainty and a link to the full review.
Three narrower questions, answered separately
The comparison pages cover the whole field. If your question is sharper than “who should I use”, these rankings scope to it — and two of them reorder the same providers on a basis this hub does not use, ranking on whether a company charges you less when you take less rather than on its headline monthly rate.
Only the providers that publish a tirzepatide price you can read before an intake, sorted by what that price does at a quarter dose. Providers without a verified recurring tirzepatide price are listed separately from the price ranking.
Every provider here with a route other than an injection. It opens with the part the category buries: there is no FDA-approved oral tirzepatide, and most of what is sold under that name has no absorption data behind it at all.
Want the side-by-side again? Back to the price ladder — with links to every provider's comparison and review. “Optional” labs means the provider may offer or suggest testing but does not gate the basic plan on it. Confirm current terms with the provider before starting.
About CoreAge Rx, our featured partner
CoreAge pays us a commission and is listed first for that reason. What it sells: named microdosing products — Semaglutide Microdosing Therapy at $149/month and Tirzepatide Microdosing Therapy at $199/month — beside standard semaglutide at $99/month and tirzepatide at $149/month, each priced the same at every dose. So the dedicated low-dose product is the dearer option here, which is worth knowing before you choose. A clinician reviews the intake, there is no membership fee, and if you are not approved you are refunded automatically.
We are also honest about the science: there are no dedicated trials showing that intentionally microdosing GLP-1s delivers the metabolic benefits seen at therapeutic doses, and compounded GLP-1s are not FDA-approved products. Nothing on this page is a promise of results. Read the full picture in our microdosing GLP-1 evidence review before deciding.
This page is informational and not medical advice. GLP-1 medications are available by prescription after clinician review; compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label with no dedicated clinical trials. Talk to a licensed provider about whether it is appropriate for you.